Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 19Lung Neoplasms 4Squamous Cell Carcinoma of Head and Neck 2Ovarian Neoplasms 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Squamous-Cell Lung Cancer 1Small Cell Lung Carcinoma 1Retinoblastoma 1Retinal Neoplasms 1Resectable Lung Non-Small Cell Carcinoma 1Recurrence 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Cancer Recurrent 1Oropharyngeal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1NSCLC 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Carcinoma, Bronchogenic 1Bronchial Neoplasms 1Advanced Non Small Cell Lung Cancer 1Adenocarcinoma of Lung 1

Interventions

nedaplatin 1X-Rays 1Specimen Handling 1Protons 1Proton Therapy 1Platinum Compounds 1Pemetrexed 1Paclitaxel 1Docetaxel 1Cisplatin 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Resectable Lung Non-Small Cell Carcinoma × Platinum Compounds × Clear all
NCT06775275 2025-01-15

A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC

The First Affiliated Hospital of Guangzhou Medical University

Phase 2 Recruiting
60 enrolled

Resectable Lung Non-Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡